1. Home
  2. ZDGE vs IMMP Comparison

ZDGE vs IMMP Comparison

Compare ZDGE & IMMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zedge Inc. Class B

ZDGE

Zedge Inc. Class B

SELL

Current Price

$2.71

Market Cap

39.2M

Sector

Technology

ML Signal

SELL

Logo Immutep Limited

IMMP

Immutep Limited

HOLD

Current Price

$3.26

Market Cap

31.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZDGE
IMMP
Founded
2008
1987
Country
United States
Australia
Employees
55
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.2M
31.5M
IPO Year
2016
2012

Fundamental Metrics

Financial Performance
Metric
ZDGE
IMMP
Price
$2.71
$3.26
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
52.9K
★ 154.6K
Earning Date
10-26-2026
09-01-2026
Dividend Yield
★ 2.92%
N/A
EPS Growth
★ 73.85
N/A
EPS
N/A
★ N/A
Revenue
★ $29,398,000.00
N/A
Revenue This Year
$6.30
N/A
Revenue Next Year
$0.76
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$2.21
$0.26
52 Week High
$4.70
$5.36

Technical Indicators

Market Signals
Indicator
ZDGE
IMMP
Relative Strength Index (RSI) 32.56 59.14
Support Level $2.57 $2.65
Resistance Level $3.14 $5.36
Average True Range (ATR) 0.10 0.28
MACD -0.03 -0.12
Stochastic Oscillator 0.00 5.22

Price Performance

Historical Comparison
ZDGE
IMMP

About ZDGE Zedge Inc. Class B

Zedge Inc builds digital marketplaces and competitive games centered on content that people use for self-expression. Its products include the Zedge App, a freemium digital content marketplace offering mobile wallpapers, video wallpapers, ringtones, and notification sounds, along with pAInt, a generative AI wallpaper and ringtone maker, GuruShots, a skill-based photo challenge game, and Emojipedia, a trusted source for emoji information. The Zedge App is available on Google Play and the App Store. The company operates two segments: Zedge Marketplace and GuruShots, with the majority of revenue generated from the Zedge Marketplace.

About IMMP Immutep Limited

Immutep Ltd is a clinical-stage biotechnology company developing novel Lymphocyte Activation Gene-3 (LAG-3) related immunotherapies for cancer and autoimmune disease. It has a diversified product portfolio that harnesses LAG-3's ability to stimulate the body's immune response to fight cancer or suppress the immune system to treat autoimmune disease. The company is focused on advancing its product candidate, eftilagimod alfa (efti), through its registrational Phase three clinical trial towards marketing approval in first-line non-small cell lung cancer (1L NSCLC). The other product candidates in its portfolio include TACTI-003, AIPAC-003, TACTI-002, INSIGHT-005, and others, being developed as potential therapies for various cancers and autoimmune diseases.

Share on Social Networks: